“◐의외로◑여탑 ∈ yeotop4.com ∋매교동오피✈매교동출장❄매교동오피ಅ매교동풀싸롱✎매교동립카페Ⅱ매교동휴게텔○매교동건마”的搜索结果，显示 621-630 项，共有 12245 项

1. 神经科- 临床试验- 妙佑医疗国际

   The objectives of this study are to determine the Maximum Tolerated Dose (MTD) and the Recommended Phase 2 Dose (RP2D) of NMS-03305293 in combination with ...

2. 神经科- 临床试验- 妙佑医疗国际

   The purpose of phase 2 of this trial is to evaluate the effectiveness of sequentially administering temozolomide and selinexor in recurrent glioblastoma as ...

3. 神经科- 临床试验- 妙佑医疗国际

   The objectives of this study are to determine the Maximum Tolerated Dose (MTD) and the Recommended Phase 2 Dose (RP2D) of NMS-03305293 in combination with ...

4. 神经科- 临床试验- 妙佑医疗国际

   Rochester, Minn. The purpose of this study is to collect blood samples for DNA analysis from patients clinically diagnosed with Alzheimers disease, Lewy Body ...

5. 神经科- 临床试验- 妙佑医疗国际

   The objectives of this study are to determine the Maximum Tolerated Dose (MTD) and the Recommended Phase 2 Dose (RP2D) of NMS-03305293 in combination with ...

6. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   This phase II trials studies how well acalabrutinib with or without obinutuzumab works in treating participants with early-stage chronic lymphocytic ...

7. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... 2-year progression free survival (PFS) rate as compared to ACNS0122. Also, to improve disease control by decreasing the number of spinal relapses for ...

8. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... 2-year progression free survival (PFS) rate as compared to ACNS0122. Also, to improve disease control by decreasing the number of spinal relapses for ...

9. 神经科- 临床试验- 妙佑医疗国际

   The objectives of this study are to determine the Maximum Tolerated Dose (MTD) and the Recommended Phase 2 Dose (RP2D) of NMS-03305293 in combination with ...

10. 神经科- 临床试验- 妙佑医疗国际

    The purpose of this study is to explore the translational abilities of desorption electrospray ionization mass spectrometry (DESI-MS) as intraoperative ...